Evaluating the safety and efficacy of the leukotriene receptor antagonist montelukast as adjuvant therapy in obese patients with type 2 diabetes mellitus: A double-blind, randomized, placebo-controlled trial

Evaluating the safety and efficacy of the leukotriene receptor antagonist montelukast as adjuvant therapy in obese patients with type 2 diabetes mellitus: A double-blind, randomized, placebo-controlled trial

Background: Type 2 diabetes mellitus (T2DM) is common with obesity. Metformin is a first-line therapy for this condition. However, it has only a minor impact on weight loss in some patients.Aim: This study aimed to evaluate the effectiveness, tolerability, and safety of combining montelukast therapy...

Full description

Saved in:
Bibliographic Details
Main Authors: Eman El-Khateeb (Author), Eman I. El-Berri (Author), Esraa M. Mosalam (Author), Mohamed Z. Nooh (Author), Shimaa Abdelsattar (Author), Amira M. Alghamdi (Author), Sarah Alrubia (Author), Mahmoud S. Abdallah (Author)
Format: Book
Published: Frontiers Media S.A., 2023-04-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items